Clinical Trials Directory

Trials / Completed

CompletedNCT03704987

Skeletal Health of Klinefelter Patients

Skeletal Health of Klinefelter Patients is Not so Bad

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
247 (actual)
Sponsor
TC Erciyes University · Academic / Other
Sex
Male
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study compared the bone health of KS patients who were actively monitored in our clinic by dual-energy X-ray absorptiometry (DXA) with that of a control group of healthy volunteers.

Detailed description

Klinefelter syndrome (KS) is the most common chromosome number abnormality of men, occurring in 1/500 to 1/1000 live births . It was first described in 1942 as an endocrine disorder characterised by small, hard testicles androgen deficiency, gynaecomastia and increased follicle stimulating hormone (FSH). Osteoporosis is a progressive bone remodelling disorder in which bone loss exceeds bone formation. The resulting micro-architectural defects and bone fragility are associated with increased fracture risk and mortality. In KS, testosterone deficiency is associated with decreased bone mass and low bone mineral density (BMD) , and a positive correlation of total serum testosterone and BMD has been reported . There are some exceptions ; however, most studies have reported that KS increases the risk of osteopenia and osteoporosis compared with age-matched control groups.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTdual-energy X-ray absorptiometrydual-energy X-ray absorptiometry

Timeline

Start date
2015-01-01
Primary completion
2017-07-31
Completion
2017-08-31
First posted
2018-10-15
Last updated
2018-10-15

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03704987. Inclusion in this directory is not an endorsement.

Skeletal Health of Klinefelter Patients (NCT03704987) · Clinical Trials Directory